Multidisciplinary Approach including Receptor Radionuclide Therapy with 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-OCTREOTIDE) and 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3]-OCTREOTATE) in Ectopic Cushing Syndrome from Ametastatic Gastrinoma: A Promising Proposal-Reference-Cited by-同舟云学术

Multidisciplinary Approach including Receptor Radionuclide Therapy with 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-OCTREOTIDE) and 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3]-OCTREOTATE) in Ectopic Cushing Syndrome from Ametastatic Gastrinoma: A Promising Proposal

Published:2008-03 Issue:2 Volume:14 Page:213-218
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Davì Maria Vittoria,Bodei Lisa,Ferdeghini Marco,Falconi Massimo,Testoni Marco,Paganelli Giovanni,Oliani Cristina,Cascio Vincenzo Lo,Francia Giuseppe

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/W6J018QUW2385226.pdf

Reference21 articles.

1. Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas;Amikura;Surgery.,1995

2. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health;Ilias;J Clin Endocrinol Metab.,2005

3. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up;Isidori;J Clin Endocrinol Metab.,2006

4. Ectopic adrenocorticotropic hormone syndrome [published correction appears in Endocr Rev. 1995;16:507];Wajchenberg;Endocr Rev.,1994

5. Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant?;Doppman;Radiology.,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies;Expert Opinion on Pharmacotherapy;2016-09-23

2. Ectopic Corticotropin-Producing Neuroendocrine Tumor of the Pancreas Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy;Clinical Nuclear Medicine;2016-01

3. Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications;Chemical Reviews;2015-04-13

4. Somatostatin Receptor Based Imaging and Radionuclide Therapy;BioMed Research International;2015

5. Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study;European Journal of Nuclear Medicine and Molecular Imaging;2011-09-03